Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.

Tseng A, Seet J, Phillips EJ.

Br J Clin Pharmacol. 2015 Feb;79(2):182-94. doi: 10.1111/bcp.12403. Review.

2.

The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.

Michaud V, Bar-Magen T, Turgeon J, Flockhart D, Desta Z, Wainberg MA.

Pharmacol Rev. 2012 Jul;64(3):803-33. doi: 10.1124/pr.111.005553. Review.

3.

Drug interactions and antiretroviral drug monitoring.

Foy M, Sperati CJ, Lucas GM, Estrella MM.

Curr HIV/AIDS Rep. 2014 Sep;11(3):212-22. doi: 10.1007/s11904-014-0212-1. Review.

4.

Pharmacogenetics of antiretroviral therapy.

Barreiro P, Fernández-Montero JV, de Mendoza C, Labarga P, Soriano V.

Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1119-30. doi: 10.1517/17425255.2014.930128. Epub 2014 Jun 18. Review.

PMID:
24941049
5.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
6.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.

7.

Pros and cons of therapeutic drug monitoring of antiretroviral agents.

Burger DM, Aarnoutse RE, Hugen PW.

Curr Opin Infect Dis. 2002 Feb;15(1):17-22.

PMID:
11964901
8.

Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view.

Clevenbergh P, Mouly S, Sellier P, Badsi E, Cervoni J, Vincent V, Trout H, Bergmann JF.

Curr HIV Res. 2004 Oct;2(4):309-21. Review.

PMID:
15544452
9.

Pharmacogenomics of CYP3A: considerations for HIV treatment.

Lakhman SS, Ma Q, Morse GD.

Pharmacogenomics. 2009 Aug;10(8):1323-39. doi: 10.2217/pgs.09.53. Review.

10.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
11.

Optimized antiretroviral therapy: the role of therapeutic drug monitoring and pharmacogenomics.

van Heeswijk RP.

Expert Rev Anti Infect Ther. 2003 Jun;1(1):75-81. Review.

PMID:
15482103
12.

Assessment and predictors of antiretroviral adherence in older HIV-infected patients.

Wutoh AK, Elekwachi O, Clarke-Tasker V, Daftary M, Powell NJ, Campusano G.

J Acquir Immune Defic Syndr. 2003 Jun 1;33 Suppl 2:S106-14.

PMID:
12853859
13.

Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update.

Cressey TR, Lallemant M.

Infect Genet Evol. 2007 Mar;7(2):333-42. Epub 2006 Oct 11. Review.

PMID:
17045554
14.

Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems.

Kumar S, Rao PS, Earla R, Kumar A.

Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):343-55. doi: 10.1517/17425255.2015.996546. Epub 2014 Dec 24. Review.

15.

Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.

Justesen US.

Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):20-31. Review.

16.

The Role of Metabolizing Enzymes and Transporters in Antiretroviral Therapy.

Ye L, Hou C, Liu S.

Curr Top Med Chem. 2017;17(3):340-360. Review.

PMID:
27572079
17.

HIV and pharmacogenomics in 2007.

Khoo S.

Pharmacogenomics. 2007 Jan;8(1):25-7.

18.

HIV drug interactions: the good, the bad, and the other.

Rainey PM.

Ther Drug Monit. 2002 Feb;24(1):26-31. Review.

PMID:
11805718
19.

[New challenges in therapeutic management of human immunodeficiency virus-infected children].

Faye A.

Arch Pediatr. 2007 Feb;14(2):212-8. Epub 2007 Jan 10. French.

PMID:
17222540
20.

Supplemental Content

Support Center